On October 24, 2023, the company has issued 42 units at an issue price of $25,000 for gross proceeds of $1,050,000 in its third tranche closing. In this connection, the company paid a placement agent fees of $157,500.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0388 USD | -1.65% | +1.31% | +1.31% |
1st Jan change | Capi. | |
---|---|---|
+1.31% | 15.75M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- OTLC Stock
- News Oncotelic Therapeutics, Inc.
- Oncotelic Therapeutics, Inc. announces tranche update